The evidence leans negative0 supporting, 3 against, 0 worth knowing
Supporting
nothing the data supports either way
Against
trading 17% below its 200-day average
at 14% of its 52-week range — nearly everyone who bought in the past year is underwater
down 25% over twelve months
Worth knowing
nothing the data supports either way
What would change this read: a close back above 317, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
0 of 47 matched on 2026-08-21
GODIGIT matches none of the 47 scans today.
Not matched by any of the 47 scans on 2026-08-21. Most stocks match nothing on most days — that is what makes a match worth looking at.
Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Order win filings were typically +0.20pt vs the market over the next 5 sessions (n=408)
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-7.9%
Versus 200-day average-17.1%
Below 52-week high-28.1%
Above 52-week low+7.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)50.1
Higher closes in last 53 of 5
Six-month return−23.46%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.